Purine-rich foods: An innocent bystander of gout attacks?

Annals of the Rheumatic Diseases

Volumn 71, Issue 9, 2012, Pages 1435-1436

  Richette, Pascal ^a   Bardin, Thomas ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; FATTY ACID; FEBUXOSTAT; INTERLEUKIN 1BETA; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; PEGLOTICASE; PURINE; URATE;

ALCOHOL CONSUMPTION; CRYSTALLIZATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EDITORIAL; FOOD INTAKE; GOUT; HUMAN; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; PURINE METABOLISM; RISK FACTOR; URIC ACID BLOOD LEVEL;

DIET; FEMALE; GOUT; HUMANS; MALE; PURINES;

EID: 84864871397     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201838     Document Type: Editorial

References (27)

1. Richette P, Bardin T. Gout. Lancet 2010;375:318-28.
2. Martinon F, Petrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237-41. (Pubitemid 43372104)
3. Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther 2010;12:223.
4. Zhang Y, Chen C, Choi H, et al. Purine-rich foods intake and recurrent gout attacks. Ann Rheum Dis 2012. Published Online First 30 May 2012. doi:10.1136/ard-2011-201215.
5. Pineda C, Amezcua-Guerra LM, Solano C, et al. Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study. Arthritis Res Ther 2011;13:R4.
6. Puig JG, de Miguel E, Castillo MC, et al. Asymptomatic hyperuricemia: impact of ultrasonography. Nucleosides Nucleotides Nucleic Acids 2008;27:592-5. (Pubitemid 351948570)
7. Pascual E, Doherty M. Aspiration of normal or asymptomatic pathological joints for diagnosis and research: indications, technique and success rate. Ann Rheum Dis 2009;68:3-7.
8. Becker MA, Schumacher HR Jr, Wortmann RL, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005;353:2450-61. (Pubitemid 41781828)
9. Sundy JS, Baraf HS, Yood RA, et al. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA 2011;306:711-20.
10. Kang EH, Lee EY, Lee YJ, et al. Clinical features and risk factors of postsurgical gout. Ann Rheum Dis 2008;67:1271-5.
11. Friedman JE, Dallal RM, Lord JL. Gouty attacks occur frequently in postoperative gastric bypass patients. Surg Obes Relat Dis 2008;4:11-3.
12. Vandenberg MK, Moxley G, Breitbach SA, et al. Gout attacks in chronic alcoholics occur at lower serum urate levels than in nonalcoholics. J Rheumatol 1994;21:700-4. (Pubitemid 24126768)
13. Nishioka K, Sumida T, Iwatani M, et al. Influence of moderate drinking on purine and carbohydrate metabolism. Alcohol Clin Exp Res 2002;26:20S-5S. (Pubitemid 34913181)
14. Urano W, Yamanaka H, Tsutani H, et al. The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis. J Rheumatol 2002;29:1950-3. (Pubitemid 34988705)
15. Schlesinger N, Norquist JM, Watson DJ. Serum urate during acute gout. J Rheumatol 2009;36:1287-9.
16. Logan JA, Morrison E, McGill PE. Serum uric acid in acute gout. Ann Rheum Dis 1997;56:696-7.
17. Choi HK, Willett W, Curhan G. Fructose-rich beverages and risk of gout in women. JAMA 2010;304:2270-8.
18. Clifford A, Riumallo J, Young V, et al. Effect of oral purines on serum and urinary uric acid of normal, hyperuricemic and gouty humans. J Nutr 1976;106:428-34.
19. Choi HK, Atkinson K, Karlson EW, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004;350:1093-103. (Pubitemid 38298989)
20. Zhang Y, Woods R, Chaisson CE, et al. Alcohol consumption as a trigger of recurrent gout attacks. Am J Med 2006;119:e13-18.
21. Hunter DJ, York M, Chaisson CE, et al. Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study. J Rheumatol 2006;33:1341-5. (Pubitemid 44026423)
22. McCarty DJ Jr. Mechanisms of the crystal deposition diseases-gout and pseudogout. Ann Intern Med 1973;78:767-71.
23. Fiddis RW, Vlachos N, Calvert PD. Studies of urate crystallisation in relation to gout. Ann Rheum Dis 1983;42(Suppl 1):12-5. (Pubitemid 13037066)
24. Lopes SM, Trimbo SL, Mascioli EA, et al. Human plasma fatty acid variations and how they are related to dietary intake. Am J Clin Nutr 1991;53:628-37. (Pubitemid 21917633)
25. Joosten LA, Netea MG, Mylona E, et al. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1 beta production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum 2010;62:3237-48.
26. Giamarellos-Bourboulis EJ, Mouktaroudi M, Bodar E, et al. Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1 beta by mononuclear cells through a caspase 1-mediated process. Ann Rheum Dis 2009;68:273-8.
27. Dinarello CA. How interleukin-1 beta induces gouty arthritis. Arthritis Rheum 2010;62:3140-4.